Pipobroman

Chemical compound
  • L01AX02 (WHO)
Identifiers
  • 3-bromo-1-[4-(3-bromopropanoyl) piperazin-1-yl]-propan-1-one
CAS Number
  • 54-91-1 checkY
PubChem CID
  • 4842
IUPHAR/BPS
  • 7271
DrugBank
  • DB00236 checkY
ChemSpider
  • 4676 checkY
UNII
  • 6Q99RDT97R
KEGG
  • D00467 checkY
ChEBI
  • CHEBI:8242
ChEMBL
  • ChEMBL1585 checkY
CompTox Dashboard (EPA)
  • DTXSID7023485 Edit this at Wikidata
Chemical and physical dataFormulaC10H16Br2N2O2Molar mass356.058 g·mol−13D model (JSmol)
  • Interactive image
  • O=C(N1CCN(C(=O)CCBr)CC1)CCBr
InChI
  • InChI=1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2 checkY
  • Key:NJBFOOCLYDNZJN-UHFFFAOYSA-N checkY
  (verify)

Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent.[1] It is marketed in France and Italy.[2]

References

  1. ^ Passamonti F, Lazzarino M (September 2003). "Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman". Leukemia & Lymphoma. 44 (9): 1483–8. doi:10.3109/10428190309178768. PMID 14565648.
  2. ^ "Pipobroman". Drugs.com.
  • v
  • t
  • e
Intracellular chemotherapeutic agents / antineoplastic agents (L01)
SPs/MIs
(M phase)
Block microtubule assembly
Block microtubule disassembly
DNA replication
inhibitor
DNA precursors/
antimetabolites
(S phase)
Folic acid
Purine
Pyrimidine
Deoxyribonucleotide
Topoisomerase inhibitors
(S phase)
I
II
II+Intercalation
Crosslinking of DNA
(CCNS)
Alkylating
Platinum-based
Nonclassical
Intercalation
Photosensitizers/PDTOther
Enzyme inhibitors
Receptor antagonists
Other/ungrouped
Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e